Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 878 All time
- Disclosed funding
- $34.1B 792 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| S SolveAICompany profile Enables employees to build enterprise-grade apps using natural language with secure IT integration Enables employees to build enterprise-grade apps using natural language with secure IT integration | $45M | Series A | AI | United Kingdom | Investors | |
| K Enables contextual advertising natively inside generative AI | $20.5M | Series A | Enterprise software | United States | Investors | |
| SM Slate MedicinesCompany profile Advancing next-generation therapeutics for migraine and other headache disorders Advancing next-generation therapeutics for migraine and other headache disorders | $130M | Series A | Biotech | United States | Investors | |
| V VoiceLineCompany profile Provides voice-first AI assistant for frontline teams to automate workflows and improve real-time visibility Provides voice-first AI assistant for frontline teams to automate workflows and improve real-time visibility | €10M | Series A | Enterprise software | Germany | Investors | |
| V VerleyCompany profile Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers | €32M | Series A | Foodtech | France | Investors | |
| HH Handl HealthCompany profile Provides technology platform for designing employer-sponsored health insurance Provides technology platform for designing employer-sponsored health insurance | $14.2M | Series A | Healthtech | United States | Investors | |
| CT Centauri TherapeuticsCompany profile Develops immunotherapeutic treatments for antimicrobial infections Develops immunotherapeutic treatments for antimicrobial infections | £6M | Series A+Series A | Biotech | United Kingdom | Investors | |
| CR Circadian RiskCompany profile Circadian Risk provides software for assessing physical security risks across enterprise facilities. Circadian Risk provides software for assessing physical security risks across enterprise facilities. | $6M | Series A | Cybersecurity | United States | Investors | |
| X XflowCompany profile Provides cross-border payment infrastructure for businesses to collect international payments Provides cross-border payment infrastructure for businesses to collect international payments | $16.6M | Series A | Fintech | India | Investors | |
| H HypercoreCompany profile Provides loan management platform and AI-powered administration services for private credit funds Provides loan management platform and AI-powered administration services for private credit funds | $13.5M | Series A | Fintech | Israel | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.